EFFEXOR Drug Patent Profile
✉ Email this page to a colleague
When do Effexor patents expire, and when can generic versions of Effexor launch?
Effexor is a drug marketed by Wyeth Pharms Inc and Upjohn and is included in two NDAs.
The generic ingredient in EFFEXOR is venlafaxine hydrochloride. There are seventy-one drug master file entries for this compound. Sixty-six suppliers are listed for this compound. Additional details are available on the venlafaxine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Effexor
A generic version of EFFEXOR was approved as venlafaxine hydrochloride by TEVA on August 3rd, 2006.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for EFFEXOR?
- What are the global sales for EFFEXOR?
- What is Average Wholesale Price for EFFEXOR?
Summary for EFFEXOR
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 224 |
Clinical Trials: | 63 |
Patent Applications: | 2,087 |
Drug Prices: | Drug price information for EFFEXOR |
Drug Sales Revenues: | Drug sales revenues for EFFEXOR |
What excipients (inactive ingredients) are in EFFEXOR? | EFFEXOR excipients list |
DailyMed Link: | EFFEXOR at DailyMed |
Recent Clinical Trials for EFFEXOR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Mit Ghamr Oncology Center | Phase 4 |
Vanderbilt University Medical Center | Phase 4 |
AbbVie | Phase 4 |
Paragraph IV (Patent) Challenges for EFFEXOR
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
EFFEXOR | Tablets | venlafaxine hydrochloride | 25 mg, 37.5 mg, 50 mg, 75 mg and 100 mg | 020151 | 1 | 2005-11-03 |
US Patents and Regulatory Information for EFFEXOR
Expired US Patents for EFFEXOR
International Patents for EFFEXOR
See the table below for patents covering EFFEXOR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Slovakia | 6472000 | SPHEROID CORE, SPHEROID WITH ITS CONTENT, PHARMACEUTICAL COMPOSITION COMPRISING THEM AND METHOD FOR THEIR PRODUCING | ⤷ Sign Up |
Netherlands | 940020 | ⤷ Sign Up | |
United Kingdom | 8603901 | ⤷ Sign Up | |
Spain | 527938 | ⤷ Sign Up | |
European Patent Office | 0639374 | Nouveaux traitements utilisant des dérivés phenéthyle (New treatments using phenethyl derivatives) | ⤷ Sign Up |
Slovakia | 30197 | CAPSULED FORMULATION WITH PROLONGED RELEASING VENLAFAXINE HYDROCHLORIDE | ⤷ Sign Up |
Mexico | 9701873 | FORMULACION DE LIBERACION PROLONGADA. (EXTENDED RELEASE FORMULATION.) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for EFFEXOR
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0112669 | 96C0002 | Belgium | ⤷ Sign Up | PRODUCT NAME: MOMETASONE FUROATE; NAT. REGISTRATION NO/DATE: NL 19601 19950919; FIRST REGISTRATION: GR - 10681/89 19900622 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |